The gastrointestinal (GI) segment is a growing specialty market with significant unmet needs, many
of which are chronic and are often untreated. For over 30 years, Salix has licensed, developed and marketed
innovative products to treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel
syndrome with diarrhea, traveler’s diarrhea, opioid-induced constipation and ulcerative colitis, among many
Please click the logo below to learn more about our products in this category.